Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Senior Scientist, Purification Development and Operations, CMC Biology at Teva Pharmaceutical Inc.
Lu Wang is a Ph.D, Senior Scientist in CMC Development of Teva Biopharmaceutical Co. Dr. Wang is specialized in downstream processing of innovative protein drugs and biosimilars. She is currently managing early phase and late phase downstream process development activities for Teva biology pipeline as well as supporting tech-transfer to manufacture, and authoring regulatory filing documents such as IND and BLA. Prior to Teva, she worked in Bristol Myer Squibb for 4 years. During the past 10 years, Dr. Wang has worked on > 10 early phase molecules and two late phase molecules, one of them was lauched on 2014. Dr. Wang held Ph.D in Biochemical Engineering with two years of postdoc training in proteomics in Pacific Northwest National Lab (PNNL)